DANIELLE SHOCKLEY: Open Payments
NPI 1396265021 · OVERLAND PARK, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$293 in 15 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $400 · 2025 $293
Food & beverage: $293
| Company | Payments | Amount |
|---|---|---|
| Calliditas Therapeutics US Inc. | 2 | $63 |
| Travere Therapeutics, Inc. | 5 | $50 |
| SHIELD THERAPEUTICS INC | 1 | $42 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $38 |
| GlaxoSmithKline, LLC. | 1 | $25 |
| Xeris Pharmaceuticals, Inc. | 1 | $23 |
| IBSA Pharma Inc. | 1 | $19 |
| AKEBIA THERAPEUTICS INC | 1 | $19 |
| Novo Nordisk Inc | 1 | $14 |
Products named: TARPEYO, ACCRUFER, Kerendia, BENLYSTA, GVOKE HYPOPEN, Tirosint, Vafseo, Ozempic.
Industry payments across KS — which companies pay providers there.
